Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2022-03-28 00:00:00 ET · period of report 2022-03-24 · accession 0001209191-22-021390 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-28 | 2022-03-24 | RLAY | Catinazzo Thomas | CFO | S - Sale+OE | $30.00 | -13.3K | 54.3K | -20% | -$398.6K |
| D | 2022-03-28 | 2022-03-24 | RLAY | Catinazzo Thomas | CFO | M - OptEx | $4.12 | +13.3K | 67.5K | +24% | +$54.7K |
| D | 2022-03-28 | 2022-03-24 | RLAY | Catinazzo Thomas | CFO | M - OptEx | $0.00 | -13.3K | 26.3K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-24 | S | D | 13,286 | $30.00 | 54,259 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $30.00 to $30.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. (F2) Includes 52,165 shares underlying RSUs. |
| 2 | Common | Common Stock | 2022-03-24 | M | A | 13,286 | $4.12 | 67,545 | D | — | — | (F2) Includes 52,165 shares underlying RSUs. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-24 | M | D | 13,286 | $0.00 | 26,257 | D | $4.12 · — to 2028-04-09 | 13,286 Common Stock | (F4) Twenty-five percent (25%) of the shares underlying this option vested on April 9, 2019 and the remainder shall vest in equal quarterly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date. |